Climb Bio, Inc. (CLYM) income statement
CLYMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.19−0.09 (-0.97%)
Close on Nov 20, 2026Market cap $527.84MP/E –Yield –
Climb Bio, Inc. financial ratios
See a number that looks wrong?
Close on Nov 20, 2026Market cap $527.84MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Returns on capital | |||||||
| Return on equity | -32.1% | -46.3% | -29.7% | -30.6% | -73.2% | 150.3% | – |
| Return on assets | -31.1% | -45.1% | -28.6% | -29.4% | -48.0% | -83.9% | – |
| Return on tangible assets | -31.1% | -45.1% | -28.6% | -29.4% | -48.0% | -83.9% | – |
| Return on capital employed | -36.4% | -51.3% | -34.1% | -30.5% | -37.8% | -97.0% | – |
| NOPAT | -$53.63M | -$64.80M | -$31.82M | -$35.66M | -$28.18M | -$16.53M | – |
| Cash flow quality | |||||||
| OCF / Net income | 0.91 | 0.21 | 0.59 | 0.83 | 0.76 | 0.68 | – |
| FCF / OCF | 100.3% | 100.0% | 100.0% | – | – | – | – |
| FCF / Net income | 0.91 | 0.21 | 0.59 | – | – | – | – |
| FCF / EBITDA | 80.5% | 19.0% | – | – | – | – | – |
| Unlevered free cash flow | -$54.54M | -$15.56M | -$20.60M | – | – | – | – |
| Levered free cash flow | -$54.54M | -$15.56M | -$20.60M | – | – | – | – |
| Efficiency | |||||||
| CapEx to OCF | -0.34% | -0.00% | -0.00% | – | – | – | – |
| CapEx to depreciation | 1.92 | – | – | – | – | – | – |
| Liquidity | |||||||
| Current ratio | 15.16 | 31.41 | 38.92 | 22.04 | 24.58 | 7.18 | – |
| Quick ratio | 15.16 | 31.41 | 38.92 | 22.04 | 24.58 | 7.18 | – |
| Cash ratio | 23.01 | 30.61 | 37.70 | 20.27 | 26.76 | 6.69 | – |
| Working capital | $98.87M | $149.94M | $107.42M | $128.30M | $142.22M | $18.94M | – |
| Net current asset value | $98.58M | $149.57M | $107.39M | $128.12M | $142.21M | $18.94M | – |
| Leverage | |||||||
| Assets to equity | 1.05 | 1.03 | 1.03 | 1.05 | 1.04 | -0.99 | – |
| Per share | |||||||
| EPS (basic) | -0.88 | -1.53 | -1.30 | -1.72 | -4.24 | -10.49 | – |
| EPS (diluted) | -0.88 | -1.53 | -1.30 | -1.72 | -4.24 | -10.49 | – |
| Book value per share | 3.36 | 3.15 | 3.88 | 4.84 | 6.29 | -7.31 | – |
| Tangible book value per share | 3.36 | 3.15 | 3.88 | 4.84 | 6.29 | -7.31 | – |
| Cash per share | 3.36 | 2.24 | 3.86 | 4.65 | 6.08 | 5.99 | – |
| Operating cash flow per share | -1.14 | -0.23 | -0.74 | -1.41 | -1.36 | -4.12 | – |
| Free cash flow per share | -1.14 | -0.23 | -0.74 | – | – | – | – |
| CapEx per share | 0.0039 | 0.00 | 0.00 | – | – | – | – |
| Valuation at period end | |||||||
| Market cap | $272.74M | $121.00M | $74.16M | $97.50M | $274.04M | – | – |
| Enterprise value | $185.84M | -$72.35M | -$33.27M | -$25.12M | $128.03M | – | – |
| P/B | 1.7x | 0.6x | 0.7x | 0.8x | 1.6x | – | – |
| P/TBV | 1.7x | 0.6x | 0.7x | 0.8x | 1.6x | – | – |
| P/OCF | -5.0x | -7.8x | -3.6x | -2.6x | -7.6x | – | – |
| EV/EBITDA | – | 0.9x | – | – | – | – | – |
| EV/EBIT | – | 0.9x | 0.8x | 0.6x | – | – | – |
| EV/OCF | -3.4x | 4.6x | 1.6x | 0.7x | -3.5x | – | – |
| EV/FCF | – | 4.6x | 1.6x | – | – | – | – |
| Earnings yield | -21.9% | -61.1% | -47.4% | -46.4% | -17.3% | – | – |
| FCF yield | -20.0% | -12.9% | -27.8% | – | – | – | – |
| Per employee | |||||||
| Total employees | 28 | 17 | 9 | 30 | 19 | 19 | 19 |
| Operating profit per employee | -$2.42M | -$4.82M | -$4.48M | -$1.50M | -$1.88M | -$1.10M | – |
| Net income per employee | -$2.14M | -$4.35M | -$3.90M | -$1.51M | -$2.50M | -$1.09M | – |
| Free cash flow per employee | -$1.95M | -$915.41K | -$2.29M | – | – | – | – |
| Growth | |||||||
| EBIT 1Y growth | 17.2% | -103.6% | 10.8% | -26.5% | -70.5% | – | – |
| EBITDA 1Y growth | 17.4% | – | – | – | – | – | – |
| Net income 1Y growth | 19.0% | -110.4% | 22.4% | 4.7% | -129.7% | – | – |
| Diluted EPS 1Y growth | 42.5% | -17.7% | 24.4% | 59.4% | 59.6% | – | – |
| Operating cash flow 1Y growth | -249.3% | 24.5% | 44.9% | -3.6% | -155.9% | – | – |
| Free cash flow 1Y growth | -250.5% | 24.5% | – | – | – | – | – |
| Total assets 1Y growth | -22.8% | 96.6% | -18.2% | -22.1% | 603.3% | – | – |
| Total assets 3Y CAGR | 7.5% | 7.8% | 64.9% | – | – | – | – |
| Total assets 5Y CAGR | 46.8% | – | – | – | – | – | – |
| Total equity 1Y growth | -24.3% | 96.9% | -16.4% | -23.0% | 769.3% | -349.2% | – |
| Total equity 3Y CAGR | 7.6% | 8.2% | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.